Partnerships are critical to the continued growth and diversification of Zymeworks. Zymeworks is engaged in a number of significant partnerships with leading pharmaceutical and biotechnology companies to bring innovative therapies into clinical development. Zymeworks retains significant downstream value for products developed with our corporate partners where near-term financial milestones help to support and accelerate the development of internally wholly-owned programs. Zymeworks leverages a diverse network of academic and governmental partners during the course of research and development of its therapeutic candidates and platform technologies.

Our Corporate Partners:

Zymeworks Partner Pipeline

*BeiGene to develop and commercialize in Asia Pacific countries including China, South Korea, Australia, and New Zealand but excluding Japan.